Clint Tomlinson | Investor Relations |
Dr. Christopher Missling | President and Chief Executive Officer |
Sandra Boenisch | Principal Financial Officer |
Charles Duncan | Cantor Fitzgerald |
Robert LeBoyer | Ladenburg Thalmann |
Tom Bishop | BI Research |
Good afternoon. My name is Vanessa and I'll be your conference call operator today. Welcome to the Anavex Life Sciences Fiscal 2020 Year-end and Fourth Quarter Conference Call.
As a reminder, this conference call is being recorded. I would now like to introduce your host of today’s conference Clint Tomlinson.